Salinomycin triggers prostate cancer cell apoptosis by inducing oxidative and endoplasmic reticulum stress via suppressing Nrf2 signaling

Yu,Jianyong; Yang,Yang; Li,Shan; Meng,Peng

doi:10.3892/etm.2021.10378

Salinomycin triggers prostate cancer cell apoptosis by inducing oxidative and endoplasmic reticulum stress via suppressing Nrf2 signaling

Authors:
- Jianyong Yu
- Yang Yang
- Shan Li
- Peng Meng
View Affiliations

Affiliations: Department of Urology, Yantai Hospital of Traditional Chinese Medicine, Yantai, Shandong 264001, P.R. China, Department of Urology, Haiyang People's Hospital, Yantai, Shandong 264001, P.R. China, The Fourth Department of Oncology, Yantai Hospital of Traditional Chinese Medicine, Yantai, Shandong 264001, P.R. China
Published online on: July 1, 2021 https://doi.org/10.3892/etm.2021.10378
Article Number: 946
Copyright: © Yu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Salinomycin is a polyether antiprotozoal antibiotic that is widely used as an animal food additive. Some antifungal, antiparasitic, antiviral and anti‑inflammatory activities have been reported for salinomycin. Recently, the anti‑cancer effect of salinomycin has been demonstrated in breast cancer; however, the underlying mechanism remains unknown. The present study aimed to investigate the functional roles of salinomycin in the progression of prostate cancer cells using the DU145 and PC‑3 cell lines. Western blotting and reverse transcription‑quantitative polymerase chain reaction were performed to detect the expression of oxidative stress and endoplasmic reticulum stress‑related molecules, and flow cytometry was performed to detect the apoptosis rate of DU145 and PC‑3 cells after salinomycin treatment. The results demonstrated that salinomycin inhibited the viability and induced the apoptosis of PC‑3 and DU145 cells in a dose‑dependent manner. Furthermore, salinomycin increased the production of reactive oxygen species (ROS) and 8‑hydroxy‑2'‑deoxyguanosine (8‑OH‑dG) and the lipid peroxidation. In addition, salinomycin induced the activation of unfolded protein response and endoplasmic reticulum stress in DU145 and PC‑3 cells, as indicated by the elevated expression of binding immunoglobulin protein, activating transcription factor 4, phosphorylated eukaryotic initiation factor 2α, phosphorylated protein kinase RNA‑like endoplasmic reticulum kinase and C/EBP homologous protein. In addition, salinomycin significantly downregulated the expression of nuclear factor erythroid 2‑related factor 2 (Nrf2), heme oxygenase‑1, NAD(P)H quinone dehydrogenase 1 and glutamate‑cysteine ligase catalytic subunit and decreased the activity of the antioxidant enzymes superoxide dismutase, catalase and glutathione peroxidase in PC‑3 and DU145 cells. Furthermore, the Nrf2 activator, tert‑butylhydroquinone, significantly reversed the therapeutic effects of salinomycin by stimulating the Nrf2 pathway and increasing the activity of antioxidant enzymes. Taken together, these findings demonstrated that salinomycin may trigger apoptosis by inducing oxidative and ER stress in prostate cancer cells via suppressing Nrf2 signaling.

View Figures

View References

1	Siegel R, Naishadham D and Jemal A: Cancer statistics, 2013. CA Cancer J Clin. 63:11–30. 2013.PubMed/NCBI View Article : Google Scholar
2	Naujokat C, Fuchs D and Opelz G: Salinomycin in cancer: A new mission for an old agent. Mol Med Rep. 3:555–559. 2010.PubMed/NCBI View Article : Google Scholar
3	Huczyński A, Janczak J, Antoszczak M, Wietrzyk J, Maj E and Brzezinski B: Antiproliferative activity of salinomycin and its derivatives. Bioorg Med Chem Lett. 22:7146–7150. 2012.PubMed/NCBI View Article : Google Scholar
4	Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA and Lander ES: Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell. 138:645–659. 2009.PubMed/NCBI View Article : Google Scholar
5	Moloney JN and Cotter TG: ROS signalling in the biology of cancer. Semin Cell Dev Biol. 80:50–64. 2018.PubMed/NCBI View Article : Google Scholar
6	Mizoue T, Tokunaga S, Kasai H, Kawai K, Sato M and Kubo T: Body mass index and oxidative DNA damage: A longitudinal study. Cancer Sci. 98:1254–1258. 2007.PubMed/NCBI View Article : Google Scholar
7	Xiao MH, Xia JY, Wang ZL, Hu WX, Fan YL, Jia DY, Li J, Jing PW, Wang L and Wang YP: Ginsenoside Rg1 attenuates liver injury induced by D-galactose in mice. Exp Ther Med. 16:4100–4106. 2018.PubMed/NCBI View Article : Google Scholar
8	Chang WH, Lee CC, Yen YH and Chen HL: Oxidative damage in patients with benign prostatic hyperplasia and prostate cancer co-exposed to phthalates and to trace elements. Environ Int. 121:1179–1184. 2018.PubMed/NCBI View Article : Google Scholar
9	Arif M, Rashid A, Majeed A, Qaiser F and Razak S: Evaluation of correlation between expression of P53 and Malondialdehyde levels in prostate cancer patients. J Pak Med Assoc. 68:1373–1377. 2018.PubMed/NCBI
10	Zhang G, Wang W, Yao C, Ren J, Zhang S and Han M: Salinomycin overcomes radioresistance in nasopharyngeal carcinoma cells by inhibiting Nrf2 level and promoting ROS generation. Biomed Pharmacother. 91:147–154. 2017.PubMed/NCBI View Article : Google Scholar
11	Zhou J, Li P, Xue X, He S, Kuang Y, Zhao H, Chen S, Zhi Q and Guo X: Salinomycin induces apoptosis in cisplatin-resistant colorectal cancer cells by accumulation of reactive oxygen species. Toxicol Lett. 222:139–145. 2013.PubMed/NCBI View Article : Google Scholar
12	Li T, Su L, Zhong N, Hao X, Zhong D, Singhal S and Liu X: Salinomycin induces cell death with autophagy through activation of endoplasmic reticulum stress in human cancer cells. Autophagy. 9:1057–1068. 2013.PubMed/NCBI View Article : Google Scholar
13	Ketola K, Hilvo M, Hyötyläinen T, Vuoristo A, Ruskeepää AL, Orešič M, Kallioniemi O and Iljin K: Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress. Br J Cancer. 106:99–106. 2012.PubMed/NCBI View Article : Google Scholar
14	Li T, Liu X, Shen Q, Yang W, Huo Z, Liu Q, Jiao H and Chen J: Salinomycin exerts anti-angiogenic and anti-tumorigenic activities by inhibiting vascular endothelial growth factor receptor 2-mediated angiogenesis. Oncotarget. 7:26580–26592. 2016.PubMed/NCBI View Article : Google Scholar
15	Wu D, Zhang Y, Huang J, Fan Z, Shi F and Wang S: Salinomycin inhibits proliferation and induces apoptosis of human nasopharyngeal carcinoma cell in vitro and suppresses tumor growth in vivo. Biochem Biophys Res Commun. 443:712–717. 2014.PubMed/NCBI View Article : Google Scholar
16	Zhang Y, Li F, Liu L, Jiang H, Hu H, Du X, Ge X, Cao J and Wang Y: Salinomycin triggers endoplasmic reticulum stress through ATP2A3 upregulation in PC-3 cells. BMC Cancer. 19(381)2019.PubMed/NCBI View Article : Google Scholar
17	Menegon S, Columbano A and Giordano S: The dual roles of Nrf2 in cancer. Trends Mol Med. 22:578–593. 2016.PubMed/NCBI View Article : Google Scholar
18	Lau A, Villeneuve NF, Sun Z, Wong PK and Zhang DD: Dual roles of Nrf2 in cancer. Pharmacol Res. 58:262–270. 2008.PubMed/NCBI View Article : Google Scholar
19	Kubben N, Zhang W, Wang L, Voss TC, Yang J, Qu J, Liu GH and Misteli T: Repression of the antioxidant Nrf2 pathway in premature aging. Cell. 165:1361–1374. 2016.PubMed/NCBI View Article : Google Scholar
20	Zhou L, Zhang H, Davies KJA and Forman HJ: Aging-related decline in the induction of Nrf2-regulated antioxidant genes in human bronchial epithelial cells. Redox Biol. 14:35–40. 2018.PubMed/NCBI View Article : Google Scholar
21	Shibata T, Ohta T, Tong KI, Kokubu A, Odogawa R, Tsuta K, Asamura H, Yamamoto M and Hirohashi S: Cancer related mutations in Nrf2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy. Proc Natl Acad Sci USA. 105:13568–13573. 2008.PubMed/NCBI View Article : Google Scholar
22	Kim KY, Park KI, Kim SH, Yu SN, Park SG, Kim YW, Seo YK, Ma JY and Ahn SC: Inhibition of autophagy promotes salinomycin-induced apoptosis via reactive oxygen species-mediated PI3K/AKT/mTOR and ERK/p38 MAPK-dependent signaling in human prostate cancer cells. Int J Mol Sci. 18(1088)2017.PubMed/NCBI View Article : Google Scholar
23	Xiong Y, Wang Y, Zhang J, Zhao N, Zhang H, Zhang A, Zhao D, Yu Z, Yin Y, Song L, et al: hPMSCs protects against D-galactose-induced oxidative damage of CD4⁺ T cells through activating Akt-mediated Nrf2 antioxidant signaling. Stem Cell Res Ther. 11(468)2020.PubMed/NCBI View Article : Google Scholar
24	Wang Y, Xiong Y, Zhang A, Zhao N, Zhang J, Zhao D, Yu Z, Xu N, Yin Y, Luan X, et al: Oligosaccharide attenuates aging-related liver dysfunction by activating Nrf2 antioxidant signaling. Food Sci Nutr. 8:3872–3881. 2020.PubMed/NCBI View Article : Google Scholar
25	Xiong Y, Xiong Y, Zhou S, Yu Z, Zhao D, Wang Z, Li Y, Yan J, Cai Y and Zhang W: Inhibition of glutathione synthesis induced by exhaustive running exercise via the decreased influx rate of L-cysteine in rat erythrocytes. Cell Physiol Biochem. 40:1410–1421. 2016.PubMed/NCBI View Article : Google Scholar
26	Stasiolek M, Adamczewski Z, Sliwka PW, Puła B, Karwowski B, Merecz-Sadowska A, Dedecjus M and Lewiński A: The molecular effect of diagnostic absorbed doses from ¹³¹I on papillary thyroid cancer cells in vitro. Molecules. 22(993)2017.PubMed/NCBI View Article : Google Scholar
27	Xiong Y, Xiong Y, Zhou S, Sun Y, Zhao Y, Ren X, Zhang Y and Zhang N: Vitamin C and E supplements enhance the antioxidant capacity of erythrocytes obtained from aged rats. Rejuvenation Res. 20:85–92. 2017.PubMed/NCBI View Article : Google Scholar
28	Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG and Hoekstra WG: Selenium: Biochemical role as a component of glutathione peroxidase. Science. 179:588–590. 1973.PubMed/NCBI View Article : Google Scholar
29	Góth L: A simple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta. 196:143–151. 1991.PubMed/NCBI View Article : Google Scholar
30	Sun Y, Oberley LW and Li Y: A simple method for clinical assay of superoxide dismutase. Clin Chem. 34:497–500. 1988.PubMed/NCBI
31	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
32	Dewangan J, Srivastava S and Rath SK: Salinomycin: A new paradigm in cancer therapy. Tumour Biol. 39(1010428317695035)2017.PubMed/NCBI View Article : Google Scholar
33	Hail N Jr and Lotan R: Cancer chemoprevention and mitochondria: Targeting apoptosis in transformed cells via the disruption of mitochondrial bioenergetics/redox state. Mol Nutr Food Res. 53:49–67. 2009.PubMed/NCBI View Article : Google Scholar
34	Yadav RK, Chae SW, Kim HR and Chae HJ: Endoplasmic reticulum stress and cancer. J Cancer Prev. 19:75–88. 2014.PubMed/NCBI View Article : Google Scholar
35	Lin Y, Jiang M, Chen W, Zhao T and Wei Y: Cancer and ER stress: Mutual crosstalk between autophagy, oxidative stress and inflammatory response. Biomed Pharmacother. 118(109249)2019.PubMed/NCBI View Article : Google Scholar
36	Li W, Yang J, Luo L, Jiang M, Qin B, Yin H, Zhu C, Yuan X, Zhang J, Luo Z, et al: Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death. Nat Commun. 10(3349)2019.PubMed/NCBI View Article : Google Scholar
37	Jeong S, Kim DY, Kang SH, Yun HK, Kim JL, Kim BR, Park SH, Na YJ, Jo MJ, Jeong YA, et al: Docosahexaenoic acid enhances oxaliplatin-induced autophagic cell death via the ER stress/Sesn2 pathway in colorectal cancer. Cancers (Basel). 11(982)2019.PubMed/NCBI View Article : Google Scholar
38	Peñaranda Fajardo NM, Meijer C and Kruyt FA: The endoplasmic reticulum stress/unfolded protein response in gliomagenesis, tumor progression and as a therapeutic target in glioblastoma. Biochem Pharmacol. 118:1–8. 2016.PubMed/NCBI View Article : Google Scholar
39	Shen Y, Yang J, Zhao J, Xiao C, Xu C and Xiang Y: The switch from ER stress-induced apoptosis to autophagy via ROS-mediated JNK/p62 signals: A survival mechanism in methotrexate-resistant choriocarcinoma cells. Exp Cell Res. 334:207–218. 2015.PubMed/NCBI View Article : Google Scholar
40	Xian M, Cao H, Cao J, Shao X, Zhu D, Zhang N, Huang P, Li W, Yang B, Ying M, et al: Bortezomib sensitizes human osteosarcoma cells to adriamycin-induced apoptosis through ROS-dependent activation of p-eIF2α/ATF4/CHOP axis. Int J Cancer. 141:1029–1041. 2017.PubMed/NCBI View Article : Google Scholar
41	Wardyn JD, Ponsford AH and Sanderson CM: Dissecting molecular cross-talk between Nrf2 and NF-κB response pathways. Biochem Soc Trans. 43:621–626. 2015.PubMed/NCBI View Article : Google Scholar
42	Wang Y, Xiong Y, Zhang A, Zhao N, Zhang J, Zhao D, Yu Z, Xu N, Yin Y, Luan X, et al: Oligosaccharide attenuates aging-related liver dysfunction by activating Nrf2 antioxidant signaling. Food Sci Nutr. 8:3872–3881. 2020.PubMed/NCBI View Article : Google Scholar
43	Towers CG, Fitzwalter BE, Regan D, Goodspeed A, Morgan MJ, Liu CW, Gustafson DL and Thorburn A: Cancer cells upregulate Nrf2 signaling to adapt to autophagy inhibition. Dev Cell. 50:690–703.e6. 2019.PubMed/NCBI View Article : Google Scholar
44	Rodrigues C, Milkovic L, Bujak IT, Tomljanovic M, Soveral G and Cipak Gasparovic A: Lipid profile and aquaporin expression under oxidative stress in breast cancer cells of different malignancies. Oxid Med Cell Longev. 2019(2061830)2019.PubMed/NCBI View Article : Google Scholar
45	Zhang XQ, Yao C, Bian WH, Chen X, Xue JX, Zhu ZY, Ying Y, Xu YL and Wang C: Effects of Astragaloside IV on treatment of breast cancer cells execute possibly through regulation of Nrf2 via PI3K/AKT/mTOR signaling pathway. Food Sci Nutr. 7:3403–3413. 2019.PubMed/NCBI View Article : Google Scholar